Instil Bio, INC. (TIL) — 10-Q Filings

10-Q Filings (6)

• Instil Bio Narrows Q3 Loss, Boosts R&D Amid Asset Sale — Nov 13, 2025 Risk: high
  Instil Bio, Inc. reported a net loss of $13.587 million for the three months ended September 30, 2025, a significant improvement from the $23.021 million net lo
• Instil Bio's Losses Widen Amid R&D Costs, Tarzana Facility Sale — Aug 13, 2025 Risk: high
  Instil Bio, Inc. reported a net loss of $21.394 million for the three months ended June 30, 2025, an increase from $14.917 million in the prior year period, and
• Instil Bio Files Q1 2025 10-Q — May 13, 2025 Risk: medium
  Instil Bio, Inc. filed its Q1 2025 10-Q report on May 13, 2025, detailing its financial position as of March 31, 2025. The company, operating in the biological
• Instil Bio Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  Instil Bio, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter
• Instil Bio, Inc. Files Q2 2024 10-Q Report — Aug 13, 2024 Risk: medium
  Instil Bio, Inc. filed its 10-Q report for the quarterly period ended June 30, 2024. The company is incorporated in Delaware and its principal executive offices
• Instil Bio, Inc. Files 10-Q for Q1 2024 — May 10, 2024 Risk: low
  Instil Bio, Inc. (TIL) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Instil Bio, Inc. filed its 10-Q for the period ending March 31, 2024. The f

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX